Structure.jpg (Image 01)
Palonosetron Hydrochloride Injection
Product Images NDC 36000-326
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Palonosetron Hydrochloride (NDC 36000-326). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Table Image.jpg (Image 02)
Table Image 3.jpg (Image 03)
Table Image 2.jpg (Image 04)
Carton-label (Image 05)
Container-label (Image 06)
This is a description of the drug Palonosetron with the National Drug Code (NDC) 36000-326-01. It is advised to be stored between 15°C to 30°C (59°F to 86°F) in a controlled room temperature area. However, it can be stored between 20°C to 25°C (68°F to 77°F), with permitted excursions. This drug comes in a 5 mL single-dose sterile vial and should be protected from freezing and light. Moreover, this injection is meant for intravenous administration only and any unused portion should be discarded. This drug was manufactured by Baxter Oncology GmbH and is manufactured for Baxter Healthcare Corporation, in the USA with the manufacturing date of September 15, 2021.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
